Published in Biotech Business Week, August 22nd, 2005
Gorman holds the chair of pharmaceutical microbiology and is head of the School of Pharmacy of Queen's University, Belfast. Gorman established the successful Biomaterials Program within the School of Pharmacy to examine the problems of bacterial contamination of medical devices and implants. His particular interest is in the development of biocompatible and biomimetic biomaterials resistant to bacterial infection. The Biomaterials Program has ongoing research associated with medical devices in urology, respiratory, orthopedics and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.